Tuesday 08 Apr, 2025 11:39 PM
Site map | Locate Us | Login
   Transformers and Rectifiers spurts after strong Q4 numbers    Mazagon Dock gains as turnover climbs 14% YoY in FY25    Medico Remedies gains after securing Rs 16-cr supply order    Jio Financial rallies as NBFC arm forays into digital lending via app    Desco Infratech hits the roof on bagging LoA from BPCL worth Rs 12-cr    Delhivery Ltd leads losers in 'A' group    Kanpur Plastipack Ltd leads losers in 'B' group    Keystone Realtors spurts as collections rise 11% YoY in Q4; surpassing GDV guidance for FY25    Volumes spurt at Vijaya Diagnostic Centre Ltd counter    Sanathan Textiles edges higher after ICRA revises rating outlook to 'positive'    HUDCO jumps on Rs 1.5 lakh crore infra funding MoU with MMRDA    International Conveyors gains on Rs 3 cr investment in TD Power Systems    GRSE rises on inking MoU with SWAN Defence    Info Edge spurts as billings climb 19% YoY in Q4 FY25    Bajaj Healthcare gains after acquiring WHO-GMP certified firm Genrx Pharma 
Saravan Stocks
       
Profit and Loss
Sun Pharmaceutical Industries Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value(R) NSE Symbol Div & Yield % Market Cap (Rs.Cr) P/E(TTM) EPS(TTM) Face Value(R)
524715 INE044A01036 98.3315118 SUNPHARMA 0.81 400293.05 127.06 13.13 1
 Mar 2024
(Rs.Cr)
Mar 2023
(Rs.Cr)
Mar 2022
(Rs.Cr)
Mar 2021
(Rs.Cr)
Mar 2020
(Rs.Cr)
Mar 2019
(Rs.Cr)
INCOME :      
Sales Turnover 20275.1720812.1415585.9814116.0512531.9310303.21
Excise Duty0.000.000.000.000.000.00
Net Sales20275.1720812.1415585.9814116.0512531.9310303.21
Other Income 553.48329.291196.88192.071510.921271.44
Stock Adjustments -180.32237.93183.18179.64-138.60251.30
Total Income20648.3321379.3616966.0414487.7613904.2511825.95
EXPENDITURE :      
Raw Materials 5423.796292.095833.575287.124429.123924.56
Power & Fuel Cost450.42495.21422.33384.16394.74407.28
Employee Cost 2373.952156.952000.781805.981702.771571.34
Other Manufacturing Expenses 1195.301037.321064.32862.12860.05898.51
Selling & Administrative Expenses 4754.864326.423514.053309.621919.251503.17
Miscellaneous Expenses 615.663257.272086.08479.24375.751707.77
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Total Expenditure14813.9817565.2614921.1312128.249681.6810012.63
Operating Profit5834.353814.102044.912359.524222.571813.32
Interest 784.08472.18388.10267.52408.01540.92
Gross Profit5050.273341.921656.812092.003814.561272.40
Depreciation1600.621600.871349.951236.43561.56552.95
Profit Before Tax3449.651741.05306.86855.573253.00719.45
Tax546.10752.77-553.58244.91386.461.55
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax45.37-702.44960.43-231.74-344.60-98.70
Reported Net Profit2858.181690.72-99.99842.403211.14816.60
Extraordinary Items -193.46-1665.671237.51-63.64193.27-1048.68
Adjusted Net Profit3051.643356.39-1337.50906.043017.871865.28
Adjustment below Net Profit -19.867.38-14.532675.94-211.5210.17
P & L Balance brought forward12790.8813612.0815964.5514005.2712384.6112037.00
Statutory Appropriations0.000.000.000.000.000.00
Appropriations 2898.162519.302237.951559.061378.96479.16
P & L Balance carried down12731.0412790.8813612.0815964.5514005.2712384.61
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %1350.001150.001000.00750.00400.00275.00
Dividend Per Share(Rs)13.5011.5010.007.504.002.75
Earnings Per Share-Unit Curr11.917.05-0.423.5113.383.40
Earnings Per Share(Adj)-Unit Curr11.917.05-0.423.5113.383.40
Book Value-Unit Curr98.7698.98102.48112.28101.6895.21
Book Value(Adj)-Unit Curr98.7698.98102.48112.28101.6895.21
   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 40071673
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd